Recent Updates
Recently added Catalysts
RIGL Positive Sentiment Score: 80/100

Rigel to Present at the Jefferies London Healthcare Conference

Monday, November 6, 2023 1 min read
Key Takeaway: Rigel Pharmaceuticals, Inc. has announced that its CFO, Dean Schorno, will present a company overview at the Jefferies 2023 London Healthcare Conference scheduled for November 14, 2023. The event will provide an opportunity for Rigel to highlight its work in developing therapies for hematologic disorders and cancer. Rigel emphasizes its commitment to improving patient outcomes through novel treatment options. Interested parties can access the presentation through the Investor Relations section of Rigel's website.

Market Sentiment Analysis

POSITIVE FACTORS

  • Upcoming presentation at a significant healthcare conference
  • Opportunity to share insights with investors
  • Focus on improving therapies for serious health conditions

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., Nov. 6, 2023 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Dean Schorno, the company's chief financial officer, will present a company overview at the Jefferies 2023 London Healthcare Conference on Tuesday, November 14, 2023 at 3:30 p.m. GMT (10:30 a.m. EST).
To access the live webcast or archived recording, visit the Investor Relations section of the company's website at www.rigel.com. Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com.
Investors & Media Contacts:
Rigel Pharmaceuticals, Inc.
Email: [email protected]
SOURCE Rigel Pharmaceuticals, Inc.

21 %

more press release views with

Frequently Asked Questions

When will Rigel Pharmaceuticals present at the Jefferies conference?

Rigel Pharmaceuticals will present on November 14, 2023, at 3:30 p.m. GMT.

How can I access Rigel Pharmaceuticals' webcast?

You can access the webcast via the Investor Relations section of Rigel's website.

What is the focus of Rigel Pharmaceuticals?

Rigel Pharmaceuticals focuses on creating therapies for hematologic disorders and cancer.

Where is Rigel Pharmaceuticals located?

Rigel Pharmaceuticals is based in South San Francisco, California.

What year was Rigel Pharmaceuticals founded?

Rigel Pharmaceuticals was founded in 1996.

Tags: RIGL Viatris Investor Conferences Healthcare Jefferies conference biotechnology healthcare South San Francisco
Last updated: Nov 6, 2023